Search

Home > Lung Cancer Considered > FDA Approval: Taletrectinib and ROS1 NSCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Taletrectinib and ROS1 NSCLC
Category: Science & Medicine
Duration: 00:29:20
Publish Date: 2025-06-24 13:00:14
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for NSCLC with a ROS1 gene fusion. Dr. Enriqueta Felip and Dr. Jorge Nieva join the conversation to help review the data and offer help place this new agent in the proper perspective.
Total Play: 0